Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Change in Accured Expenses (2016 - 2025)

Celcuity's (CELC) quarterly Change in Accured Expenses came in at $11.1 million in Q4 2025, up 320.93% YoY from $2.6 million in Q4 2024, and up 606.79% on a QoQ basis from -$2.2 million in Q3 2025.

Analysis

Celcuity (CELC) Change in Accured Expenses (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Change in Accured Expenses data on file, last reported at $11.1 million in Q4 2025.

  • Quarterly Change in Accured Expenses rose 320.93% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.4 million (up 410.72% YoY) and the FY2025 annual result came in at $15.4 million, up 410.72% from the prior year.
  • Change in Accured Expenses improved to $11.1 million in Q4 2025, from -$2.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $11.1 million in Q4 2025 to a low of -$5.0 million in Q4 2024.
  • A 5-year average of $1.3 million and a median of $731978.5 in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2021 — Change in Accured Expenses sank 533.84% — and 2022, when it surged 4232.71%.
  • Tracing CELC's Change in Accured Expenses over 5 years: stood at -$76959.0 in 2021, then soared by 1382.46% to $986965.0 in 2022, then surged by 106.69% to $2.0 million in 2023, then plunged by 346.82% to -$5.0 million in 2024, then soared by 320.93% to $11.1 million in 2025.
  • The last three Change in Accured Expenses figures came in at $11.1 million (Q4 2025), -$2.2 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.12 Mn
Sep 30, 2025 2.08 Mn
Jun 30, 2025 1.55 Mn
Mar 31, 2025 633,000.00
Dec 31, 2024 -5.04 Mn
Sep 30, 2024 3.83 Mn
Jun 30, 2024 1.92 Mn
Mar 31, 2024 2.30 Mn
Dec 31, 2023 2.04 Mn
Sep 30, 2023 3.02 Mn
Jun 30, 2023 830,957.00
Mar 31, 2023 -1.02 Mn
Dec 31, 2022 986,965.00
Sep 30, 2022 1.40 Mn
Jun 30, 2022 461,913.00
Mar 31, 2022 413,499.00
Dec 31, 2021 -76,959.00
Sep 30, 2021 230,179.00
Jun 30, 2021 -11,177.00
Mar 31, 2021 -113,763.00